NSMCE2 and breast cancer: Importantly, by generating NSMCE2 knockdown breast cancer cell lines, we showed that NSMCE2 plays a key role in resistance to doxorubicin treatment, probably due to its DNA repairing function, which reduces doxorubicin’s DNA damaging effect and prevents the activation of the apoptotic program.